Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Developments of isoCombretastatin A-4 derivatives as highly cytotoxic agents
Abdallah Hamzé, Mouâd Alami, Olivier Provot
European Journal of Medicinal Chemistry (2020) Vol. 190, pp. 112110-112110
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

More Than Resveratrol: New Insights into Stilbene-Based Compounds
Paulina Pecyna, Joanna Warguła, Marek Murias, et al.
Biomolecules (2020) Vol. 10, Iss. 8, pp. 1111-1111
Open Access | Times Cited: 116
Controlling Reactivity and Selectivity in the Mizoroki–Heck Reaction: High Throughput Evaluation of 1,5-Diaza-3,7-diphosphacyclooctane Ligands
Eric S. Isbrandt, Devon E. Chapple, Nguyễn Thiên Phúc Từ, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 8, pp. 5650-5660
Open Access | Times Cited: 7
Discovery of N-benzylarylamide derivatives as novel tubulin polymerization inhibitors capable of activating the Hippo pathway
Jian Song, Shenghui Wang, Chun-Hong Song, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114583-114583
Closed Access | Times Cited: 26
Design, synthesis and biological evaluation of quinoline-2-carbonitrile-based hydroxamic acids as dual tubulin polymerization and histone deacetylases inhibitors
Camille Hauguel, Sarah Ducellier, Olivier Provot, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114573-114573
Open Access | Times Cited: 25
Structure modification and biological evaluation of indole-chalcone derivatives as anti-tumor agents through dual targeting tubulin and TrxR
Jun Yan, Yuzhu Xu, Xing Jin, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113897-113897
Closed Access | Times Cited: 32
Anticancer properties of indole derivatives as IsoCombretastatin A-4 analogues
Shannon Pecnard, Abdallah Hamzé, Jérôme Bignon, et al.
European Journal of Medicinal Chemistry (2021) Vol. 223, pp. 113656-113656
Open Access | Times Cited: 28
Discovery of a Novel Stilbene Derivative as a Microtubule Targeting Agent Capable of Inducing Cell Ferroptosis
Jingwei Zhou, Yanqing Pang, Weiwei Zhang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 6, pp. 4687-4708
Closed Access | Times Cited: 21
Bioactive stilbenes from plants
Xin Su, Di Zhou, Ning Li
Studies in natural products chemistry (2022), pp. 265-403
Closed Access | Times Cited: 20
Design, synthesis, and bioevaluation of 1 h -pyrrolo[3,2- c ]pyridine derivatives as colchicine-binding site inhibitors with potent anticancer activities
Chao Wang, Yujing Zhang, Shanbo Yang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 4
Candida antarctica Lipase B mediated kinetic resolution: A sustainable method for chiral synthesis of antiproliferative β-lactams
Eavan C. McLoughlin, Brendan Twamley, Niamh M. O’Boyle
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116692-116692
Open Access | Times Cited: 4
Recent Trends in Tubulin-Binding Combretastatin A-4 Analogs for Anticancer Drug Development
Paidakula Suresh, Srinivas Nerella, Shravankumar Kankala, et al.
Current Medicinal Chemistry (2021) Vol. 29, Iss. 21, pp. 3748-3773
Closed Access | Times Cited: 24
High-performance liquid chromatography-based evaluation of lipophilicity of a series of novel stilbene derivatives
S.S. Georgieva, Tsvetomil Voyslavov, Christo D. Chanev, et al.
Pharmacia (2025) Vol. 72, pp. 1-8
Open Access
Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors
Runlai Liu, Mingxin Huang, Shuai Zhang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113826-113826
Closed Access | Times Cited: 19
Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors
Li Liu, Devin O’Kelly, Regan Schuetze, et al.
Molecules (2021) Vol. 26, Iss. 9, pp. 2551-2551
Open Access | Times Cited: 18
Cyclic bridged analogs of isoCA-4: Design, synthesis and biological evaluation
Shannon Pecnard, Olivier Provot, Hélène Levaïque, et al.
European Journal of Medicinal Chemistry (2020) Vol. 209, pp. 112873-112873
Open Access | Times Cited: 19
Novel combretastatin A-4 derivative containing aminophosphonates as dual inhibitors of tubulin and matrix metalloproteinases for lung cancer treatment
Xiaochao Huang, Yuanhang Chen, Wentian Zhong, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114817-114817
Closed Access | Times Cited: 12
Recent clinical trials and optical control as a potential strategy to develop microtubule-targeting drugs in colorectal cancer management
Katsuhiro Kita, Allen Burdowski
World Journal of Gastroenterology (2024) Vol. 30, Iss. 13, pp. 1780-1790
Open Access | Times Cited: 2
Medicinal chemistry perspective on the structure–activity relationship of stilbene derivatives
Saghi Sepehri, Mina Khedmati, Faeze Yousefnejad, et al.
RSC Advances (2024) Vol. 14, Iss. 28, pp. 19823-19879
Open Access | Times Cited: 2
Synthesis and biological evaluation of novel hybrids of phenylsulfonyl furoxan and phenstatin derivatives as potent anti-tumor agents
Xin Huang, Yu-Shuang Wang, Duo Ma, et al.
European Journal of Medicinal Chemistry (2022) Vol. 230, pp. 114112-114112
Closed Access | Times Cited: 9
Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4
Azizah M. Malebari, Shu Wang, Thomas F. Greene, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 11, pp. 1119-1119
Open Access | Times Cited: 11
Targeting the tumor microenvironment by an enzyme-responsive prodrug of tubulin destabilizer for triple-negative breast cancer therapy with high safety
Yingyuan Peng, Zhixian Shi, Yuru Liang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 236, pp. 114344-114344
Closed Access | Times Cited: 8
Design, synthesis and biological evaluation of 9-aryl-5H-pyrido[4,3-b]indole derivatives as potential tubulin polymerization inhibitors
Lingyu Shi, Shanbo Yang, Jing Chang, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 8
Design, Synthesis and Bioevaluation of Novel Trifluoromethylquinoline Derivatives As Tubulin Polymerization Inhibitors
Sisi Zhang, Min Mo, Mengfan Lv, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 21, pp. 1967-1986
Closed Access | Times Cited: 4
Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors
Li Liu, Devin O’Kelly, Regan Schuetze, et al.
(2021)
Open Access | Times Cited: 8
Combretastatin A-4 analogs: Past, present, and future directions
Muhamad Mustafa, Yaser A. Mostafa, Atef E. Abd El-Baky, et al.
Deleted Journal (2022)
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top